How do you choose the right DPP-4 inhibitor for your patients with type 2 diabetes?
Onglyza Therapeutic Indications
Onglyza is indicated in adults with type 2 diabetes mellitus to improve glycaemic control in combination with diet and exercise as:
(i) monotherapy when metformin is inappropriate due to intolerance or contraindications;
(ii) in combination with other medicinal products for the treatment of diabetes including insulin when these do not provide adequate glycaemic control.
1. ONGLYZA® Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/22315 (Last accessed August 2017).